Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System®-PR Newswire APAC
- Written by PR Newswire
Funds to be Used for Commercial Expansion in Europe and Australia
KIRKLAND, Washington, Sept. 29, 2020 /PRNewswire/ -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the company has closed a $17.5 million...
